Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TINF2 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
mRNA | ZNF423 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
mRNA | ATP13A1 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | UBE2T | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
mRNA | ZNF567 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | CT62 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.002 |
mRNA | AL513122.2 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.002 |
mRNA | AL513122.1 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.002 |
mRNA | STARD9 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
mRNA | LBR | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |